Online inquiry

IVTScrip™ mRNA-Human ANKRD28, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK15214MR)

This product GTTS-WK15214MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methoxy-UTP. It ecodes the ANKRD28 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methoxy-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001195098.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23243
UniProt ID O15084
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD28, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) (GTTS-WK15214MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK23795MR IVTScrip™ mRNA-Human ARHGAP30, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP30
GTTS-WK28669MR IVTScrip™ mRNA-Human ARPC4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARPC4
GTTS-WK26556MR IVTScrip™ mRNA-Human ARMC5, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARMC5
GTTS-WK18230MR IVTScrip™ mRNA-Human ANKRD50, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD50
GTTS-WK16799MR IVTScrip™ mRNA-Human APBB1IP, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APBB1IP
GTTS-WK9201MR IVTScrip™ mRNA-Human ADAMTS17, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS17
GTTS-WK15736MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA alpha-Sarcoglycan
GTTS-WK15204MR IVTScrip™ mRNA-Human ANKRD18A, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD18A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →